Medical Staff Pulse Newsletter

Meetings and Events

Reversing Heart Disease
March 12

Ethics Noon Conference
March 20

Virtual Medicine Symposium
March 27

These events and more can be found in the medical staff calendar on the Cedars-Sinai website.

Grand Rounds

Upcoming CME Conferences


Do you know of a significant event in the life of a medical staff member? Please let us know, and we'll post these milestones in Medical Staff Pulse. Also, feel free to submit comments on milestones, and we'll post the comments in the next issue.

Submit your milestones and comments.

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

FDA Issues Warnings About Medications

The U.S. Food and Drug Administration (FDA) is warning there is an increased risk of death with Uloric (febuxostat) compared to another gout medicine, allopurinol. The FDA is instructing healthcare professionals to reserve Uloric for use only in patients who have failed or do not tolerate allopurinol.

The FDA website has more information.

FDA: Xeljanz, Xeljanz XR Warning

The FDA is warning that a safety clinical trial found an increased risk of blood clots in the lungs and death when a 10-mg, twice-daily dose of tofacitinib (Xeljanz, Xeljanz XR) was used in patients with rheumatoid arthritis. Healthcare professionals should follow the recommendations in the tofacitinib prescribing information for the specific condition they are treating.

The FDA website has more information.